Shachindra L Nargund
Also known as: S L Nargund
Nargund College of Pharmacy, Bengaluru
About
1. We work on Synthesis of novel heterocyclic Molecules in the area of carcinoma, anti-bacterials, anti-angiogenesis, Inhibitors and enzyme inhibition potential molecules. Thienopyrimidine, Benzothiazoles, Benzimidazoles, Triazoles and triazines. Nitrogen and flour containing molecules are our strong areas.
2. We work of development of polymeric delivery platforms in the area of targeted therapy, nano particulate systems, sustained release platforms with adopt a biodegradable system to have a better cytotoxicity profile of our developed platforms.
3. Formulation development is our addition to the entire project we undertake so that we can develop scale products which are industry ready or we collaborate with the industry and develop jointly commercial viable products.
Employment
-
Nargund College of Pharmacy, Bengaluru Professor/Head2007 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (14)
- Emerging Role of Benzimidazole-Loaded Nanoparticles in Targeted Drug Delivery and Cancer Therapy: A review Save
- Nanotechnology-Enabled Thienopyrimidines: A Frontier in Targeted Drug Delivery Save
- Structure-Based Molecular Docking and ADME Profiling of Novel Thienopyrimidines as Dual VEGFR/EGFR Inhibitors in Colorectal Cancer Save
- Rheumatoid Arthritis and novel carrier systems in diagnosis and treatment: An AI generated review Save
- Ufasomes: A comprehensive review of design, characterization and applications Save
- A Sustainable Microwave Protocol for the Synthesis of Benzimidazole Scaffolds Save
- “Green and Sustainable Synthesis of Thienopyrimidine Derivatives: A Review of Methods and Medicinal Applications” Save
- A Review on Pyrrole Derivatives in Medicinal Chemistry: From Natural Products to Modern Therapeutics Save
- Spirooxindole Derivatives as Anticancer Agents: A Comprehensive Review on Synthetic Strategies (2019 2025) Save
- Thienopyrimidines as Novel Modulators of G Quadruplex Structures: Emerging Opportunities in Genome Targeted Therapy Save